BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24626092)

  • 21. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
    Smirnov DA; Foulk BW; Doyle GV; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2006 Mar; 66(6):2918-22. PubMed ID: 16540638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic surgery protects against the oncologic adverse effects of open surgery by attenuating endothelial progenitor cell mobilization.
    Condon ET; Barry BD; Wang JH; Kirwan WO; Redmond HP
    Surg Endosc; 2007 Jan; 21(1):87-90. PubMed ID: 17063295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients.
    Ronzoni M; Manzoni M; Mariucci S; Loupakis F; Brugnatelli S; Bencardino K; Rovati B; Tinelli C; Falcone A; Villa E; Danova M
    Ann Oncol; 2010 Dec; 21(12):2382-2389. PubMed ID: 20497963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aneuploid Circulating Tumor-Derived Endothelial Cell (CTEC): A Novel Versatile Player in Tumor Neovascularization and Cancer Metastasis.
    Lin PP
    Cells; 2020 Jun; 9(6):. PubMed ID: 32599893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer.
    Fleitas T; Martínez-Sales V; Vila V; Reganon E; Mesado D; Martín M; Gómez-Codina J; Montalar J; Reynés G
    PLoS One; 2012; 7(10):e47365. PubMed ID: 23077602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating endothelial cells and circulating endothelial progenitors.
    Mancuso P; Calleri A; Bertolini F
    Recent Results Cancer Res; 2012; 195():163-70. PubMed ID: 22527503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor endothelial cell-derived cadherin-2 promotes angiogenesis and has prognostic significance for lung adenocarcinoma.
    Zhuo H; Zhao Y; Cheng X; Xu M; Wang L; Lin L; Lyu Z; Hong X; Cai J
    Mol Cancer; 2019 Mar; 18(1):34. PubMed ID: 30832661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis.
    Fürstenberger G; von Moos R; Senn HJ; Boneberg EM
    Br J Cancer; 2005 Oct; 93(7):793-8. PubMed ID: 16160694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High speed flow cytometry allows the detection of circulating endothelial cells in hemangioblastoma patients.
    De Biasi S; Gibellini L; Feletti A; Pavesi G; Bianchini E; Lo Tartaro D; Pecorini S; De Gaetano A; Pullano R; Boraldi F; Nasi M; Pinti M; Cossarizza A
    Methods; 2018 Feb; 134-135():3-10. PubMed ID: 29133210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients.
    Beerepoot LV; Mehra N; Vermaat JS; Zonnenberg BA; Gebbink MF; Voest EE
    Ann Oncol; 2004 Jan; 15(1):139-45. PubMed ID: 14679134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating endothelial cell (CEC) as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM).
    Yoneda K; Tanaka F; Kondo N; Orui H; Hashimoto M; Takuwa T; Matsumoto S; Okumura Y; Tsubota N; Sato A; Tsujimura T; Kuribayashi K; Fukuoka K; Nakano T; Hasegawa S
    Ann Surg Oncol; 2012 Dec; 19(13):4229-37. PubMed ID: 22825770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating endothelial cells as biomarkers in clinical oncology.
    Mancuso P; Bertolini F
    Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects.
    Mariucci S; Rovati B; Bencardino K; Manzoni M; Danova M
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e40-8. PubMed ID: 20088999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating endothelial and endothelial progenitor cells in non-small-cell lung cancer.
    Fleitas T; Martínez-Sales V; Gómez-Codina J; Martín M; Reynés G
    Clin Transl Oncol; 2010 Aug; 12(8):521-5. PubMed ID: 20709649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy.
    Yap R; Veliceasa D; Emmenegger U; Kerbel RS; McKay LM; Henkin J; Volpert OV
    Clin Cancer Res; 2005 Sep; 11(18):6678-85. PubMed ID: 16166447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy.
    Duda DG; Cohen KS; di Tomaso E; Au P; Klein RJ; Scadden DT; Willett CG; Jain RK
    J Clin Oncol; 2006 Mar; 24(9):1449-53. PubMed ID: 16549839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance.
    Scharovsky OG; Binda MM; Rozados VR; Bhagat S; Cher ML; Bonfil RD
    Clin Exp Metastasis; 2004; 21(2):177-83. PubMed ID: 15168735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The recruitment of exogenous endothelial progenitor cells in lung tumor model of nude mice.
    Peng Q; Liu M; Song SM; Li XH; Du YH; Zhi Y; Wang MY
    Chin J Cancer; 2010 Nov; 29(11):952-8. PubMed ID: 20979695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma.
    Daly S; Kubasiak JC; Rinewalt D; Pithadia R; Basu S; Fhied C; Lobato GC; Seder CW; Hong E; Warren WH; Chmielewski G; Liptay MJ; Bonomi P; Borgia JA
    Ann Thorac Surg; 2014 Dec; 98(6):1968-75; discussion 1975. PubMed ID: 25301368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.
    Bidard FC; Mathiot C; Degeorges A; Etienne-Grimaldi MC; Delva R; Pivot X; Veyret C; Bergougnoux L; de Cremoux P; Milano G; Pierga JY
    Ann Oncol; 2010 Sep; 21(9):1765-1771. PubMed ID: 20233745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.